Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:1095 (8 May), doi:10.1136/bmj.328.7448.1095
BMJ Gavin Yamey
After months of angry disputes between different global health agencies about how best to reduce deaths from malaria in Africa, the disputing parties—Unicef, the World Health Organization, and Médecins Sans Frontières—came together in New York last week to present a united face and declare that artemisinin based combination therapy (ACT) must urgently be made available across Africa.
In a joint consensus statement, the three agencies—together with Columbia University’s school of public health, which hosted the meeting—acknowledged that "expanding access to ACT is increasingly a matter of life and death for people at risk of malaria," and they committed themselves to "discontinuing support for the use of ineffective medicines."
Dr Jean-Marie Kindermans of Médecins Sans Frontières said that his organisation’s call for Unicef and the Roll Back Malaria partnership to implement ACT "has not been smooth sailing." He therefore welcomed the statement but cautioned that the rhetoric must
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?